Expleo Solutions Q1 FY27 Results & Earnings Intelligence

EXPLEOSOL

Structural risk assessment following Q1-FY27 | 30 Jun 26 earnings.

Flagium AI Risk Score✅
StableRisk: 16/100
1 warning12Q Forensic Surveillance ✓
Total Revenue / Income

₹298.5 Cr

+12.0% YoY•-0.1% QoQ

Profit Before Tax (PBT)

₹44.2 Cr

+56.0% YoY•-13.1% QoQ

Net Profit (PAT)

₹34.2 Cr

+67.3% YoY•-18.0% QoQ

Risk Score (QoQ)

16/ 100

+8 pts QoQ

The Quarter at a Glance

Consolidated Financials
Total Revenue / IncomeQ1-FY27 | 30 Jun 26
₹298.5 Cr
YoYQ1-FY26 | 30 Jun 25
₹266.6 Cr+12.0%
QoQQ4-FY26 | 31 Mar 26
₹298.9 Cr-0.1%
Profit Before Tax (PBT)Q1-FY27 | 30 Jun 26
₹44.2 Cr
YoYQ1-FY26 | 30 Jun 25
₹28.4 Cr+56.0%
QoQQ4-FY26 | 31 Mar 26
₹50.9 Cr-13.1%
Net Profit (PAT)Q1-FY27 | 30 Jun 26
₹34.2 Cr
YoYQ1-FY26 | 30 Jun 25
₹20.4 Cr+67.3%
QoQQ4-FY26 | 31 Mar 26
₹41.7 Cr-18.0%

Sources:Official BSE/NSE Disclosures & Financial Filings

Sentinel Executive Summary

Core Earnings Synthesis

"Expleo Solutions currently sits within Flagium's Stable category. However, recent periods have remained stable with minor operational friction. Despite positive top and bottom-line growth, triggers like 'Governance Integrity Shock' indicate underlying structural risk. Current deterioration appears cyclical rather than existential."

Expleo Solutions posted steady top-line growth and bottom-line stability, demonstrating resilient execution in its core markets. While the underlying business remains fundamentally sound, the presence of 1 active risk warnings highlights minor operational or working capital inefficiencies to keep on the watch list.

🟢 Key Operational & Structural Positives

  • ✓Revenue Growth: Quarterly revenue moved +12.0% YoY and -0.1% QoQ, reflecting demand and volume trends.
  • ✓Net Profit Expansion: Profit after tax moved +67.3% YoY and -18.0% QoQ, settling at ₹34.2 Cr.
  • ✓Operating Margins: Operating margin moved +419 bps YoY and -151 bps QoQ to 14.82%.

⚠️ Key Areas of Watch & Margin Pressures

  • ⚠TCV deal intake conversions into billable revenue.
  • ⚠Operating margin protection against wage hikes and employee costs.
  • ⚠Discretionary tech spend recovery in key markets.
YoY vs QoQ Seasonality BridgeSequential Normalization vs Annual Growth
Flagium Forensic Seasonality Lens

Total Revenue / Income grew +12.0% YoY, but moderated -0.1% QoQ vs Q4-FY26. This divergence typically reflects seasonal lumpiness or elevated base in prior quarters rather than secular deterioration; underlying annual growth remains intact. Similarly, Net Profit (PAT) moderated -18.0% QoQ while maintaining +67.3% YoY.

Flagium Risk Signals

Automated Forensic Signals
Quarterly Risk Trajectory (Q4-FY26 | 31 Mar 26 → Q1-FY27 | 30 Jun 26)

Governance Integrity Shock

CategoryGovernance Signals
SignalGovernance Integrity Shock
SeverityModerate

EXPLEOSOL: Key governance event detected: DIRECTOR_RESIGNATION.

Capital Allocation & Shareholder Return

Dividend

Board approved capital distribution for Q1-FY27

Dividend per Share

₹110.00 / share

Approved by Board
Record Date

01-Aug-2026

Shareholder Cut-off
Payout vs EPS

Reported

Earnings Backed
Disbursement

Within 30 Days

Statutory Window
Flagium Capital Discipline Note: Board approved an dividend of ₹110.00 / share.

🎙️ Expleo Solutions (EXPLEOSOL) Q1 FY27 Concall Intelligence

Management Commentary, Concall Takeaways & Key Discussion Themes

🎙

No earnings call transcript was available

for this reporting period.

Sentinel AI · Q1 FY27 Forensic Copilot

What to do next

Continue Research

📬 Flagium Risk Brief — Track forensic risks on EXPLEOSOL & 3 market anomalies weekly

See a sample issue →

Methodology & Regulatory Disclaimer

Flagium AI is an automated financial data analytics platform. Analysis reports are compiled programmatically from public regulatory XBRL submissions (NSE/BSE) for educational and research purposes only. Flagium AI is not registered with SEBI as a Research Analyst or Investment Adviser under SEBI regulations. This evaluation does not constitute investment advice, financial planning, or recommendations to buy, sell, or hold any security.

Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered Investment Adviser before acting on any data presented.